4//SEC Filing
KEANE WILLIAM P 4
Accession 0001209191-12-032823
CIK 0001009356other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:40 PM ET
Size
8.6 KB
Accession
0001209191-12-032823
Insider Transaction Report
Form 4
KEANE WILLIAM P
Director
Transactions
- Sale
Common Stock
2012-06-05$51.67/sh−10,000$516,692→ 33,202 total
Holdings
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying) - 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying) - 30,000
Option to Buy Common Stock
Exercise: $15.25Exp: 2014-01-14→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.43 to $51.96, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001204286
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:40 PM ET
- Size
- 8.6 KB